DE69017543D1 - Acetylcholinesterase-Inhibitoren. - Google Patents

Acetylcholinesterase-Inhibitoren.

Info

Publication number
DE69017543D1
DE69017543D1 DE69017543T DE69017543T DE69017543D1 DE 69017543 D1 DE69017543 D1 DE 69017543D1 DE 69017543 T DE69017543 T DE 69017543T DE 69017543 T DE69017543 T DE 69017543T DE 69017543 D1 DE69017543 D1 DE 69017543D1
Authority
DE
Germany
Prior art keywords
acetylcholinesterase inhibitors
acetylcholinesterase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69017543T
Other languages
English (en)
Other versions
DE69017543T2 (de
Inventor
Daniel Schirlin
Jean-Noel Collard
Jean-Marie Hornsperger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of DE69017543D1 publication Critical patent/DE69017543D1/de
Publication of DE69017543T2 publication Critical patent/DE69017543T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
DE69017543T 1989-06-22 1990-06-20 Acetylcholinesterase-Inhibitoren. Expired - Lifetime DE69017543T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89401775A EP0403713A1 (de) 1989-06-22 1989-06-22 Acetylcholinesterase-Inhibitoren

Publications (2)

Publication Number Publication Date
DE69017543D1 true DE69017543D1 (de) 1995-04-13
DE69017543T2 DE69017543T2 (de) 1995-07-06

Family

ID=8202963

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69017543T Expired - Lifetime DE69017543T2 (de) 1989-06-22 1990-06-20 Acetylcholinesterase-Inhibitoren.

Country Status (19)

Country Link
EP (2) EP0403713A1 (de)
JP (1) JP2879951B2 (de)
KR (1) KR0139529B1 (de)
CN (1) CN1027759C (de)
AR (1) AR247214A1 (de)
AT (1) ATE119535T1 (de)
AU (1) AU626428B2 (de)
CA (1) CA2019231C (de)
DE (1) DE69017543T2 (de)
DK (1) DK0409676T3 (de)
ES (1) ES2072406T3 (de)
FI (1) FI97619C (de)
HU (1) HU210569B (de)
IE (1) IE66155B1 (de)
IL (1) IL94779A (de)
NO (1) NO178374C (de)
NZ (1) NZ234136A (de)
PT (1) PT94449B (de)
ZA (1) ZA904715B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0611769A1 (de) * 1993-02-16 1994-08-24 Merrell Dow Pharmaceuticals Inc. Silytierte acetylcholinesterase Inhibitoren
US5523442A (en) * 1993-02-16 1996-06-04 Merrell Pharmaceuticals Inc. Silylated acetylcholinesterase inhibitors
EP0627400A1 (de) * 1993-06-04 1994-12-07 Merrell Dow Pharmaceuticals Inc. Aromatische Inhibitoren von Acetylcholinesterase
US5554780A (en) * 1994-05-05 1996-09-10 Merrell Pharmaceuticals Inc. Process for the preparation of 1-(3-trialkylsilylphenyl)-2,2,2-trifluoromethyl ethanone derivatives
US5486638A (en) * 1994-11-08 1996-01-23 Marion Merrell Dow Inc. Process for the preparation of 1-halo-3-trialkysilanyl-benzene derivatives
EP0749972A1 (de) 1995-06-21 1996-12-27 Merrell Pharmaceuticals Inc. Verfahren zur Herstellung von 1-(3-trialkylsilylphenyl)-2,2,2-trifluormethylethanonderivaten
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
CN1059702C (zh) * 1997-12-30 2000-12-20 中国科学院上海细胞生物学研究所 从哺乳类细胞中获得脑型乙酰胆碱酯酶的方法
US6218383B1 (en) 1998-08-07 2001-04-17 Targacept, Inc. Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
US6084117A (en) * 1999-11-22 2000-07-04 Albemarle Corporation Production of silated haloarenes by selective silylation of polyhaloarenes
EP2533645B1 (de) 2010-02-09 2016-07-27 The Johns Hopkins University Verfahren und zusammensetzungen zur verbesserung von kognitiven funktionen
EP2919788A4 (de) 2012-11-14 2016-05-25 Univ Johns Hopkins Verfahren und zusammensetzungen zur behandlung von schizophrenie
MX362886B (es) 2012-12-13 2019-02-22 H Lundbeck As Composición sinérgica que comprende vortioxetina y donepezilo para incrementar los niveles de acetilcolina en el cerebro, y el uso de la misma en el tratamiento de una disfunción cognitiva.
DK2968220T3 (da) 2013-03-15 2021-06-14 Agenebio Inc Fremgangsmåder og sammensætninger til forbedring af kognitiv funktion
EP2968237A4 (de) 2013-03-15 2016-08-31 Univ Johns Hopkins Verfahren und zusammensetzungen zur verbesserung der kognitiven funktion
BR112017025031B1 (pt) 2015-05-22 2023-03-21 Agenebio, Inc Composições farmacêuticas de liberação prolongada de levetiracetam

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL25820A (en) * 1966-05-22 1971-02-25 Yissum Res Dev Co Silicon containing beta-hydroxy alpha-phenyl carboxylic acids,their amide and ester derivatives and intermediates for their preparation
US4835099A (en) * 1986-11-20 1989-05-30 Becton, Dickinson And Company Signal enhancement in immunoassay by modulation of enzymatic catalysis

Also Published As

Publication number Publication date
HU210569B (en) 1995-05-29
DK0409676T3 (da) 1995-03-27
AU5758490A (en) 1991-01-03
FI903104A0 (fi) 1990-06-20
EP0409676A1 (de) 1991-01-23
HUT54695A (en) 1991-03-28
KR910000757A (ko) 1991-01-30
AU626428B2 (en) 1992-07-30
CA2019231A1 (en) 1990-12-22
CN1027759C (zh) 1995-03-01
NO902776L (no) 1990-12-27
IL94779A (en) 1996-09-12
JPH0338591A (ja) 1991-02-19
ZA904715B (en) 1991-04-24
ATE119535T1 (de) 1995-03-15
JP2879951B2 (ja) 1999-04-05
NZ234136A (en) 1994-04-27
CN1048389A (zh) 1991-01-09
DE69017543T2 (de) 1995-07-06
EP0403713A1 (de) 1990-12-27
IE902252A1 (en) 1991-01-16
FI97619B (fi) 1996-10-15
NO902776D0 (no) 1990-06-21
HU903933D0 (en) 1990-11-28
CA2019231C (en) 2000-07-11
EP0409676B1 (de) 1995-03-08
IE66155B1 (en) 1995-12-13
IE902252L (en) 1990-12-22
PT94449A (pt) 1991-02-08
ES2072406T3 (es) 1995-07-16
FI97619C (fi) 1997-01-27
PT94449B (pt) 1997-02-28
KR0139529B1 (ko) 1998-07-01
NO178374B (no) 1995-12-04
AR247214A1 (es) 1994-11-30
NO178374C (no) 1996-03-13

Similar Documents

Publication Publication Date Title
FI904101A0 (fi) 17b-acyl-4-aza-5a-androst-1-en-3-on- som 5a-reduktasinhibitorer.
DE3864608D1 (de) Hmg-coa-reduktasehemmer.
ATE131156T1 (de) Glutarimide.
DE59000343D1 (de) Schaelmesser.
NO903799L (no) Acat-inhibitorer.
NO905602D0 (no) Diazaforbindelser.
FI904729A0 (fi) Inhibitorer av retrovirala proteaser.
NO901274L (no) 5-alkylkinolonkarboksylsyrer.
DE69020982D1 (de) Vulkanisierungsform.
DE59007379D1 (de) 3-Phenylbenzofuran-2-one.
ATE119535T1 (de) Acetylcholinesterase-inhibitoren.
DE59007974D1 (de) Uretero-Renoskop.
NO904885D0 (no) Toerkeinnretning.
FI904920A0 (fi) Telefonsamtals distribueringssystem.
DE69011033D1 (de) Alpha-Glukosidase-Inhibitoren.
FI906357A0 (fi) Engaongsinjektionsspruta.
DE59004522D1 (de) Mikrodosiergerät.
DE59005135D1 (de) Formstein.
DE59008431D1 (de) Triazolylsulfonamide.
NO901257D0 (no) Kinolinderivater.
DE59009874D1 (de) Iminosilane.
DE59008846D1 (de) Fluorphenylpyrimidine.
FI890299A (fi) Form.
DE59007719D1 (de) Pyrazol-3-carbonsäureamide.
FI895771A0 (fi) Sidobegraensarsystem.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition